GC68820
Cabiralizumab
Cabiralizumab (FPA 008) is an anti-CSF1R monoclonal antibody (MAb)· Cabiralizumab can enhance T cell infiltration and anti-tumor T cell immune response· Cabiralizumab inhibits osteoclast activation and prevents bone destruction, which can be used for research on rheumatoid arthritis (RA)· Cabiralizumab can be combined with Nivolumab for lung cancer research
ChemicalCAS1613144-80-1
- CAS number
- 1613144-80-1
- Molecular weight
- —
- Formula
- —
- Catalogue number
- GC68820
- Brand
- GLPBIO
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il